Cell Systems-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=848011, encodeId=d3e8848011dc, content=这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Sat Nov 03 22:03:23 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106777, encodeId=67221106e7722, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106778, encodeId=120a1106e78a6, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570714, encodeId=36d55e07147e, content=后来怎么样了add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, beContent=add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTZwzWjb0xElyyIJibx1t1uhG1c5DCjnRlfnvjnnicd7sm9k9a5ZpxLRcjoBocjeNhUISXpxmj65HA/132, createdBy=799c35440, createdName=gaojian5643, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552164, encodeId=7e0755216424, content=今日投了一篇，希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533607, encodeId=281453360e37, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:55:00 CST 2017, time=2017-03-02, status=1, ipAttribution=)]

2018-11-03 ms1875852553058278

这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了

321 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=848011, encodeId=d3e8848011dc, content=这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Sat Nov 03 22:03:23 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106777, encodeId=67221106e7722, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106778, encodeId=120a1106e78a6, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570714, encodeId=36d55e07147e, content=后来怎么样了add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, beContent=add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTZwzWjb0xElyyIJibx1t1uhG1c5DCjnRlfnvjnnicd7sm9k9a5ZpxLRcjoBocjeNhUISXpxmj65HA/132, createdBy=799c35440, createdName=gaojian5643, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552164, encodeId=7e0755216424, content=今日投了一篇，希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533607, encodeId=281453360e37, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:55:00 CST 2017, time=2017-03-02, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

俢回包括几个方面？

100 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=848011, encodeId=d3e8848011dc, content=这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Sat Nov 03 22:03:23 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106777, encodeId=67221106e7722, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106778, encodeId=120a1106e78a6, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570714, encodeId=36d55e07147e, content=后来怎么样了add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, beContent=add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTZwzWjb0xElyyIJibx1t1uhG1c5DCjnRlfnvjnnicd7sm9k9a5ZpxLRcjoBocjeNhUISXpxmj65HA/132, createdBy=799c35440, createdName=gaojian5643, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552164, encodeId=7e0755216424, content=今日投了一篇，希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533607, encodeId=281453360e37, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:55:00 CST 2017, time=2017-03-02, status=1, ipAttribution=)]

2021-12-27 MS68862005

俢回的流程是什么？

113 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=848011, encodeId=d3e8848011dc, content=这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Sat Nov 03 22:03:23 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106777, encodeId=67221106e7722, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106778, encodeId=120a1106e78a6, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570714, encodeId=36d55e07147e, content=后来怎么样了add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, beContent=add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTZwzWjb0xElyyIJibx1t1uhG1c5DCjnRlfnvjnnicd7sm9k9a5ZpxLRcjoBocjeNhUISXpxmj65HA/132, createdBy=799c35440, createdName=gaojian5643, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552164, encodeId=7e0755216424, content=今日投了一篇，希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533607, encodeId=281453360e37, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:55:00 CST 2017, time=2017-03-02, status=1, ipAttribution=)]

2019-05-10 gaojian5643

后来怎么样了add23点3点3 2018-01-30 11:58:00 发表:
今日投了一篇，希望好运！

add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！

285 0

[GetPortalCommentsPageByObjectIdResponse(id=848011, encodeId=d3e8848011dc, content=这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Sat Nov 03 22:03:23 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106777, encodeId=67221106e7722, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106778, encodeId=120a1106e78a6, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570714, encodeId=36d55e07147e, content=后来怎么样了add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, beContent=add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTZwzWjb0xElyyIJibx1t1uhG1c5DCjnRlfnvjnnicd7sm9k9a5ZpxLRcjoBocjeNhUISXpxmj65HA/132, createdBy=799c35440, createdName=gaojian5643, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552164, encodeId=7e0755216424, content=今日投了一篇，希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533607, encodeId=281453360e37, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:55:00 CST 2017, time=2017-03-02, status=1, ipAttribution=)]

2018-01-30 咔咔咔呀呀呀

今日投了一篇，希望好运！

387 0

[GetPortalCommentsPageByObjectIdResponse(id=848011, encodeId=d3e8848011dc, content=这个杂志的编辑非要和我约稿，本来打算投cell的，就卖个人情投了，结果直接就接收了，太轻松了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Sat Nov 03 22:03:23 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106777, encodeId=67221106e7722, content=俢回包括几个方面？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106778, encodeId=120a1106e78a6, content=俢回的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570714, encodeId=36d55e07147e, content=后来怎么样了add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, beContent=add23点3点3 2018-01-30 11:58:00 发表: 今日投了一篇，希望好运！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJTZwzWjb0xElyyIJibx1t1uhG1c5DCjnRlfnvjnnicd7sm9k9a5ZpxLRcjoBocjeNhUISXpxmj65HA/132, createdBy=799c35440, createdName=gaojian5643, createdTime=Fri May 10 00:00:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552164, encodeId=7e0755216424, content=今日投了一篇，希望好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=387, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/02/a19e1a0c64f4f2aa4b05b6e2c4a4c7f6.jpg, createdBy=e8081708989, createdName=咔咔咔呀呀呀, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533607, encodeId=281453360e37, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=424, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Mar 02 08:55:00 CST 2017, time=2017-03-02, status=1, ipAttribution=)]

2017-03-02 lovetcm

审稿速度:2.0 | 投稿命中率:25.0
经验分享：这是新刊，2017年刚刚进入SCIE，但是它是Cell杂志的子刊，因此一出生就注定不一样，未来会成为系统生物学的核心刊物。如果有高水平文章，可以试试，现在应该还比较容易，再过几年就恐怕不易发表了。

424 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务